EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Given Average Recommendation of “Buy” by Brokerages
Shares of EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Get Free Report) have received an average recommendation of “Buy” from the nine ratings firms that are currently covering the stock, Marketbeat reports. Nine investment analysts have rated the stock with a buy recommendation. The average 1 year price objective among analysts that have updated their coverage on […]
Shares of EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Get Free Report) have received an average recommendation of “Buy” from the nine ratings firms that are currently covering the stock, Marketbeat reports. Nine investment analysts have rated the stock with a buy recommendation. The average 1 year price objective among analysts that have updated their coverage on […]
